These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 27352175)

  • 1. A Comparison between Two Dilute Citrate Solutions (15 vs. 18 mmol/l) in Continuous Renal Replacement Therapy: The Base Excess and Renal Substitution Solution Study.
    Anstey C; Campbell V; Richardson A
    Blood Purif; 2016; 42(3):194-201. PubMed ID: 27352175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of two regional citrate anticoagulation modalities for continuous renal replacement therapy by a prospective analysis of safety, workload, effectiveness, and cost.
    Cassina T; Villa M; Soldani-Agnello A; Zini P
    Minerva Anestesiol; 2021 Dec; 87(12):1309-1319. PubMed ID: 34527405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Safety and efficacy of regional citrate anticoagulation in continuous renal replacement therapy in the presence of acute kidney injury after hepatectomy].
    Zhang C; Lin T; Zhang J; Liang H; Di Y; Li N; Gao J; Wang W; Liu S; Wang Z; Jiang H; Liu C
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Aug; 30(8):777-782. PubMed ID: 30220281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous venovenous hemodiafiltration with a low citrate dose regional anticoagulation protocol and a phosphate-containing solution: effects on acid-base status and phosphate supplementation needs.
    Morabito S; Pistolesi V; Tritapepe L; Vitaliano E; Zeppilli L; Polistena F; Fiaccadori E; Pierucci A
    BMC Nephrol; 2013 Oct; 14():232. PubMed ID: 24156306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional citrate anticoagulation in predilution continuous venovenous hemofiltration using prismocitrate 10/2 solution.
    Shum HP; Chan KC; Yan WW
    Ther Apher Dial; 2012 Feb; 16(1):81-6. PubMed ID: 22248200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional citrate anticoagulation in CVVH: a new protocol combining citrate solution with a phosphate-containing replacement fluid.
    Morabito S; Pistolesi V; Tritapepe L; Zeppilli L; Polistena F; Fiaccadori E; Pierucci A
    Hemodial Int; 2013 Apr; 17(2):313-20. PubMed ID: 22882732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous veno-venous hemofiltration using a phosphate-containing replacement fluid in the setting of regional citrate anticoagulation.
    Morabito S; Pistolesi V; Tritapepe L; Vitaliano E; Zeppilli L; Polistena F; Fiaccadori E; Pierucci A
    Int J Artif Organs; 2013 Dec; 36(12):845-52. PubMed ID: 24362894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new system for regional citrate anticoagulation in continuous venovenous hemodialysis (CVVHD).
    Mitchell A; Daul AE; Beiderlinden M; Schäfers RF; Heemann U; Kribben A; Peters J; Philipp T; Wenzel RR
    Clin Nephrol; 2003 Feb; 59(2):106-14. PubMed ID: 12608553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simplified regional citrate anticoagulation protocol for CVVH, CVVHDF and SLED focused on the prevention of KRT-related hypophosphatemia while optimizing acid-base balance.
    Di Mario F; Sabatino A; Regolisti G; Pacchiarini MC; Greco P; Maccari C; Vizzini G; Italiano C; Pistolesi V; Morabito S; Fiaccadori E
    Nephrol Dial Transplant; 2023 Sep; 38(10):2298-2309. PubMed ID: 37037771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effects of High Level Magnesium Dialysis/Substitution Fluid on Magnesium Homeostasis under Regional Citrate Anticoagulation in Critically Ill.
    Zakharchenko M; Los F; Brodska H; Balik M
    PLoS One; 2016; 11(7):e0158179. PubMed ID: 27391902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Application of improved regional citrate anticoagulation in continuous hemofiltration in children].
    Bai K; Liu CJ; Fu YQ; Xu F
    Zhonghua Er Ke Za Zhi; 2017 May; 55(5):334-337. PubMed ID: 28482382
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparison of two citrate anticoagulation regimens for continuous veno-venous hemofiltration.
    Egi M; Naka T; Bellomo R; Cole L; French C; Trethewy C; Wan L; Langenberg CC; Fealy N; Baldwin I
    Int J Artif Organs; 2005 Dec; 28(12):1211-8. PubMed ID: 16404696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A continuous veno-venous hemofiltration protocol with anticoagulant citrate dextrose formula A and a calcium-containing replacement fluid.
    Ong SC; Wille KM; Speer R; Tolwani AJ
    Int J Artif Organs; 2014 Jun; 37(6):499-502. PubMed ID: 24811309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of citrate-based anticoagulation compared to heparin in patients with acute kidney injury requiring continuous renal replacement therapy: a randomized controlled trial.
    Stucker F; Ponte B; Tataw J; Martin PY; Wozniak H; Pugin J; Saudan P
    Crit Care; 2015 Mar; 19(1):91. PubMed ID: 25881975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulant effect of low concentration plasma trisodium citrate in continuous veno-venous hemofiltration.
    Long J; Li Z; Zhang Z; Dong X; Zhu C
    Ann Palliat Med; 2021 Aug; 10(8):8900-8908. PubMed ID: 34488377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The acid-base effect of changing citrate solution for regional anticoagulation during continuous veno-venous hemofiltration.
    Egi M; Naka T; Bellomo R; Langenberg CC; Li W; Fealy N; Baldwin I
    Int J Artif Organs; 2008 Mar; 31(3):228-36. PubMed ID: 18373316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Citrate clearance in children receiving continuous venovenous renal replacement therapy.
    Chadha V; Garg U; Warady BA; Alon US
    Pediatr Nephrol; 2002 Oct; 17(10):819-24. PubMed ID: 12376810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Choice of replacement solution and anticoagulant in continuous venovenous hemofiltration.
    Palsson R; Laliberte KA; Niles JL
    Clin Nephrol; 2006 Jan; 65(1):34-42. PubMed ID: 16429840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous venovenous hemofiltration with citrate-based replacement fluid: efficacy, safety, and impact on nutrition.
    Bihorac A; Ross EA
    Am J Kidney Dis; 2005 Nov; 46(5):908-18. PubMed ID: 16253732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous venovenous hemofiltration with or without predilution regional citrate anticoagulation: a prospective study.
    Nurmohamed SA; Vervloet MG; Girbes AR; Ter Wee PM; Groeneveld AB
    Blood Purif; 2007; 25(4):316-23. PubMed ID: 17700015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.